CDK6 and neoplasm: Divisato et al. [36] recalled the evidence for the tumor-suppressing properties of miR-29 family members; in particular, miR-29a, involved in the early differentiation of stem cells, could mediate antiproliferative effects on melanoma cells by downregulating CDK6, a regulator of the G1/S phase.